AuntMinnie.com staff writers

Nuclear Medicine
ITM promotes supply deal with Novartis for Pluvicto
German radiopharmaceutical firm ITM Isotope Technologies Munich SE (ITM) highlighted its lutetium-177 supply deal with Novartis in the wake of the U.S. Food and Drug Administration's approval of the company's Pluvicto radioligand therapy.
March 24, 2022
2018 12 11 00 02 7009 Atom Nuclear Lab 400
Breast
U.S. Senate passes act to promote breast screening for veterans
The U.S. Senate has passed the Making Advances in Mammography and Medical Options for Veterans Act, a bill drawn up to expand mammography screenings for disabled female veterans.
March 24, 2022
2021 01 23 01 46 4668 Patient Mammography Woman Tech 400
Digital X-Ray
Broncus highlights study on virtual navigation system
Software developer Broncus Medical highlighted a recent study published in the journal Respirology showing its Archimedes Virtual Bronchoscopic Navigation System is safe and effective for guiding the sampling of peripheral pulmonary lesions.
March 24, 2022
2009 12 11 14 59 36 837 Bronchus Bai Thumb
Industry News
Hologic opens Innovation Center in France
Hologic recently opened its Innovation Center in Aix-en-Provence, France, which follows the company's 2019 acquisition SuperSonic Imagine, based in the area.
March 23, 2022
2020 01 02 21 24 9838 Hologic Rsna 2019 400
Nuclear Medicine
Clarity launching trial for prostate cancer therapy
Clarity Pharmaceuticals is launching an investigator-initiated trial that will focus on the use of its copper-64 (Cu-64)-labeled radiopharmaceutical, Cu-64 SAR-bisPSMA, in prostate cancer.
March 23, 2022
2020 07 15 23 29 3710 Cancer Cells Prostate 400
Image Processing
Perspectum touts liver biomarker's performance in study
Perspectum is touting its LiverMultiScan biomarker's performance in improving autoimmune hepatitis management, the results were published on March 21 in the Lancet.
March 23, 2022
2019 05 29 19 22 3353 Liver Anatomy 400
Image Processing
Nvidia unveils Clara Holoscan MGX at GTC 2022
Nvidia has launched Clara Holoscan MGX, a hardware and software platform designed to support development and deployment of healthcare artificial intelligence (AI) applications, at this week's 2022 GPU Technology Conference (GTC).
March 22, 2022
2022 03 23 21 56 7093 2022 03 23 Nvidia 400
Nuclear Medicine
Eckert & Ziegler partners with Alpha-9 Theranostics
Isotope technology firm Eckert & Ziegler has agreed to supply lutetium-177 to the Canadian biotechnology firm Alpha-9 Theranostics for use in clinical trials.
March 22, 2022
2019 12 19 00 53 5252 Hands Shaking Deal 400
Industry News
Scanslated touts study on radiology reports for patients
Radiology software developer Scanslated is highlighting results of a study showing its radiology reporting software may improve patient understanding and engagement. The findings were published recently in the Journal of the American College of Radiology.
March 22, 2022
2022 03 23 16 06 4341 Man Office Student 400
Nuclear Medicine
Navidea reports revenue declines in Q4, all of 2021
Radiopharmaceutical developer Navidea Biopharmaceuticals reported a decline in revenues for the fourth quarter of 2021 and the entire year.
March 22, 2022
2017 04 03 18 01 52 418 Graph Arrow Down 400
Previous Page
Page 153 of 3774
Next Page
Top Stories
Prostate Imaging
Molecular Imaging
PSMA PET-guided radiotherapy shows promise
A trial demonstrated that radiotherapy informed by PSMA-PET led to improved outcomes in prostate cancer patients.
Co2 Emissions Dial Low
Practice Management
Contrast media-reduction strategies could curb emissions up to 53%
Cms Building 400 (1)
Practice Management
Does CMS 2026 proposed rule enforce efficiency at a cost to practices?
Mammogram Dense Breasts Cropped
Womens Imaging
Missed previous mammography screening linked to worse disease outcomes
Digital Innovations Shaping the Future of Radiology
Sponsor Content
Digital Innovations Shaping the Future of Radiology
More in Home
Features found on MRI may predict liver cancer recurrence after surgery
By Kate Madden Yee
An algorithm based on MRI features could help clinicians predict liver cancer recurrence after patients have undergone liver resection, researchers have found.
November 8, 2023
Preoperative axial extracellular contrast agent-enhanced (A-E) MRI and (F-H) follow-up CT images in a 71-year-old male patient with chronic hepatitis B and a serum neutrophil count of 4.2 × 109/L. A 5.6-cm mass with a 1.9-cm satellite nodule was detected in segments V and VIII. (A) The mass (asterisks, A-E) shows mild-to-moderate hyperintensity on T2-weighted images, (B) hypointensity on T1-weighted noncontrast-enhanced images, (C) less than 50% hyperenhancement on late arterial phase images, (D) nonperipheral washout and incomplete enhancing capsule on portal venous phase images, and (E) marked diffusion restriction on diffusion-weighted images (b = 800 sec/mm2). The mass was confirmed at histopathologic analysis as moderately differentiated hepatocellular carcinoma with microvascular invasion. With an advanced-stage recurrence after resection score of 19.8 points (4.2 + 5.6 + 10), this patient was assigned to the high-risk group (≥15 points) for advanced-stage recurrence. At follow-up, (F) noncontrast-enhanced, (G) arterial phase, and (H) portal venous phase CT images acquired at day 70 after surgery show multifocal intrahepatic recurrence and tumor thrombus in the left portal vein (black arrow, H). Images and caption courtesy of the RSNA.
Mammography-based nomogram predicts breast microcalcifications
By Amerigo Allegretto
A mammography-based radiomic nomogram could be useful in predicting risk of malignancy in suspicious breast microcalcifications.
November 8, 2023
Breast Mammo Computer 400 (2)
Playkits develop role in easing kids' anxiety over MRI scans
By Edna Astbury-Ward, PhD
Giving young children a playkit that uses both virtual and augmented reality appears to reduce anxiety about this procedure, U.K. researchers report.
November 8, 2023
A smartphone is a key component of the playkit devised by the Sheffield team. Photo courtesy of DYR in collaboration with Dubit UK.
PET predicts chemotherapy responses in breast cancer patients
By Will Morton
PET/CT with gallium-68 FAPI radiotracer can predict responses to neoadjuvant chemotherapy in breast cancer patients.
November 8, 2023
Representative Ga-68 FAPI-PET/CT images of 48-year-old woman who had left invasive ductal carcinoma and who achieved pathologic complete response (pCR). (A) Baseline maximum-intensity projection (MIP) image demonstrated primary lesion (red arrowhead; SUVmax, 26.72) and Ga-68 FAPI-avid lymph node in left axilla (red arrows). (B) MIP image after two cycles of neoadjuvant chemotherapy (NAC) showed that primary lesion (red arrowhead; SUVmax, 8.87) and axillary lymph nodes (red arrow) were reduced in size and radioactivity uptake. (C and D) Representative images of lab tissue staining for FAP before NAC showed strong FAP-positive staining in stromal cells (C), which was significantly decreased on tumor bed after six cycles of NAC (D). Image courtesy of the Journal of Nuclear Medicine.
20-year study shows that lung cancer screening boosts survival rates
By Kate Madden Yee
Diagnosing early-stage lung cancer with low-dose CT translates to a 20-year survival rate of 81%, according to a large-scale study.
November 7, 2023
(A, B) Two annual repeat low-dose CT scans in a woman who was 60 years old at baseline enrollment in 1999. At baseline enrollment, she was currently smoking and had a 30-pack-year smoking history. No nodules were identified on baseline low-dose CT scans. On the sixth annual low-dose CT scan (B), a right lower lobe solid nodule (arrow) measuring 4.5 mm in maximum diameter was identified. The nodule could be identified in retrospect on the prior annual CT scan (arrow in A), when it measured 2 mm in maximum diameter. Estimated tumor volume doubling time was 161 days. Lobectomy was performed two months later, and diagnosis of stage 1aN0M0 moderately differentiated adenocarcinoma measuring 6 mm in maximum diameter was made. Expert pathologic panel review (22) of the pathologic specimen updated the diagnosis to adenocarcinoma with mixed subtype (80% acinar, 20% bronchoalveolar carcinoma components) with 5 mm of invasion. Images and caption courtesy of the RSNA.
Formal training leads to improved POCUS use for surgeons
By Amerigo Allegretto
A formal point-of-care ultrasound (POCUS) curriculum can improve the use of the technology by surgeons.
November 7, 2023
Surgeons Smiling 400
Imaging and 3D printing enhance teaching of anatomy
By Will Morton
The use of cross-sectional imaging and 3D printing may enhance teaching of spinal anatomy in undergraduate medical education.
November 7, 2023
3dspine
Julianna Czum talks AI chest radiograph study with AuntMinnie.com
By Amerigo Allegretto
Julianna Czum, MD, spoke with AuntMinnie.com on a study that tested a deep-learning algorithm on triaging chest radiographs.
November 6, 2023
Julianna Czum Interview
'Moral injury' common among interventional radiologists
By Kate Madden Yee
Moral injury is common among interventional radiologists, according to a study published November 3 in Academic Radiology.
November 6, 2023
Doctor Nurse Stressed Mask 400
PET shows ApoE4 carriers may benefit from earlier AD treatment
By Will Morton
PET imaging has revealed brain pathology linked to faster clinical progression of Alzheimer’s disease (AD) in patients with ApoE4 gene variants.
November 6, 2023
Tau
Can IMGs help mitigate radiologist shortages?
By Will Morton
International medical graduates (IMGs) appear to face difficulties getting visas for employment in U.S. academic radiology departments.
November 6, 2023
Students
MRI radiomics show promise for identifying Ki-67 breast cancer
By Kate Madden Yee
MRI radiomics show a high diagnostic accuracy for predicting Ki-67 expression in breast cancer, researchers have found.
November 6, 2023
Breast Cancer 400
Previous Page
Page 153 of 175
Next Page